CapsoVision Files S-1 for Public Offering
Ticker: CV · Form: S-1 · Filed: May 9, 2025 · CIK: 1378325
| Field | Detail |
|---|---|
| Company | Capsovision, Inc (CV) |
| Form Type | S-1 |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo, registration-statement, medical-devices
TL;DR
CapsoVision just filed its S-1, looks like they're going public soon. Get ready.
AI Summary
CapsoVision, Inc. filed an S-1 registration statement on May 9, 2025, to register an unspecified number of securities. The company, incorporated in Delaware with its principal executive offices in Saratoga, CA, operates in the electromedical and electrotherapeutic apparatus industry. Kang-Huai (Johnny) Wang is listed as the President and Chief Executive Officer.
Why It Matters
This S-1 filing indicates CapsoVision, Inc. is preparing to become a publicly traded company, which could lead to increased investment and scrutiny in the electromedical device sector.
Risk Assessment
Risk Level: medium — As an S-1 filing, it represents a company in the early stages of going public, which inherently carries higher risks than established public companies.
Key Numbers
- 333-287148 — SEC File Number (Identifies the specific SEC registration)
- 25930539 — Film Number (Internal SEC processing number)
Key Players & Entities
- CapsoVision, Inc. (company) — Registrant
- May 9, 2025 (date) — Filing Date
- S-1 (document) — Filing Type
- Delaware (jurisdiction) — State of Incorporation
- Saratoga, CA (location) — Principal Executive Offices
- Kang-Huai (Johnny) Wang (person) — President and Chief Executive Officer
- 3845 (industry_code) — Standard Industrial Classification
FAQ
What is the purpose of this S-1 filing?
The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public.
When was this S-1 filing submitted?
The S-1 filing was submitted on May 9, 2025.
What is CapsoVision, Inc.'s primary business sector?
CapsoVision, Inc. operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector, with SIC code 3845.
Who is the principal executive officer of CapsoVision, Inc.?
Kang-Huai (Johnny) Wang is the President and Chief Executive Officer of CapsoVision, Inc.
Where are CapsoVision, Inc.'s principal executive offices located?
CapsoVision, Inc.'s principal executive offices are located at 18805 Cox Avenue, Suite 250, Saratoga, CA 95070.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on May 9, 2025 by Kang-Huai (Johnny) Wang regarding CapsoVision, Inc (CV).